Share
50,916 Posts.
lightbulb Created with Sketch. 2
clock Created with Sketch. 02/07/24
23:11
Share
Originally posted by Hingdog:
↑
Matey people dumped CHN because it's project metrics don't look like they stack up, even at the hopium level pricing used in the scoping study, short sellers were simply correct in their assessment. Those who got short near the highs did so because it was at an obscene valuation in an almighty bubble market, they would also know the vast majority of these projects never make it, there is no conspiracy
Expand
@Hingdog ; biotechs are about as speculative / high risk as it gets ... good luck!
